Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt)
Clinical trial NCT03566810 · COMPLETED
Trial details
- NCT number
- NCT03566810
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2018-11-28
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.